Latest Conference Articles

In this video from PainWeek 2017, Hal Blatman, MD, medical director of Blatman Health and Wellness Center, discusses the most common misconceptions that patients have about pain.

In this video from PainWeek 2017, Hal Blatman, MD, medical director of Blatman Health and Wellness Center, discusses whether the FDA should reduce the availability of high-dose opioids in response to the growing opioid abuse epidemic.

In this video from PainWeek 2017, Hal Blatman, MD, medical director of Blatman Health and Wellness Center, discusses how compounding pharmacists can help patients with chronic pain.

In this video from PainWeek 2017, Hal Blatman, MD, medical director of Blatman Health and Wellness Center, discusses the relationship between chronic pain and stress.

In this video from PainWeek 2017, Jeremy Adler, MS, PA-C, co-owner of Pacific Pain Medicine, discusses why opioid abuse has become an increasingly urgent issue.

In this video from PainWeek 2017, Jeremy Adler, MS, PA-C, co-owner of Pacific Pain Medicine, discusses the pharmacist's role in combating the opioid abuse epidemic.

In this video from PainWeek 2017, Jeremy Adler, MS, PA-C, co-owner of Pacific Pain Medicine, discusses the challenges facing abuse-deterrent opioids as their manufacturers attempt to bring them to market.

In this video from PainWeek 2017, Jeremy Adler, MS, PA-C, co-owner of Pacific Pain Medicine, discusses the mechanisms by which abuse-deterrent opioids prevent misuse.

In this video from PainWeek 2017, Jeremy Adler, MS, PA-C, co-owner of Pacific Pain Medicine, discusses the benefits of abuse-deterrent opioids.

Patients who were treated by the IPT experienced a 61% greater reduction in morphine equivalent daily dose (MEDD) than those who received usual care group.

In this video from PainWeek 2017, Hal Blatman, MD, medical director of Blatman Health and Wellness Center, discusses treatment options for sleep-related pain.

Insurers can also help address this devastating epidemic.

In response to the growing opioid abuse epidemic, several health groups have written a petition requesting that the FDA remove ultra-high dosage unit (UHDU) analgesics from the market.

Pharmacists may soon be posed to take on new roles within the growing landscape of animal health.

There are several roles pharmacists can play in managing patients with cardiovascular disease, including blood pressure and medication monitoring.

The rivaroxaban plus aspirin combination therapy to treat patients with stable coronary or peripheral artery disease showed such benefits in the COMPASS trial that it should become the standard of care.

John Rumsfeld, MD, PhD, chief innovation officer at the American College of Cardiology, discusses the vexing problem of patients who fail to fill or take recommended medications.

John Rumsfeld, MD, PhD, chief innovation officer at the American College of Cardiology, discusses the digital innovations that will have major effects on the cardiovascular field in years to come.

In this clip, Deepak Bhatt, MD, discusses how pharmacists should counsel patients taking aspirin and rivaroxaban, if approved.

In this clip, Deepak Bhatt, MD, discusses the results of the COMPASS (Cardiovascular OutcoMes for People using Anticoagulation StrategieS) trial, presented at the European Society of Cardiology Congress 2017, held August 26-30 in Barcelona, Spain.

In this clip, Steven Nissen, MD, of the Cleveland Clinic discusses some new data on anti-inflammatories and cardiovascular events that were presented this week at the European Society of Cardiology.

It is important to align pharmacy services with changes in the population.

Check out the video to learn which pharmacy students are getting recruited.

A growing number of plans have begun adjusting payment to pharmacies according to adherence rates.

Accepting some risks and investing in time and staffing are needed to build out service models.

There are 30 million Americans living with diabetes, and 84 million Americans have prediabetes.

In this clip, Brooke Hudspeth, PharmD, CDE, of the Kroger Co., explains how pharmacists can play a role in reinforcing the importance of lifestyle modifications for the prevention and management of type 2 diabetes.

In this clip, Brooke Hudspeth, PharmD, CDE, of the Kroger Co. discusses how pharmacists can educate patients about lifestyle modifications that could impact their diabetes.

Brooke Hudspeth, PharmD, CDE, of the Kroger Co., discusses the newest therapies available for type 2 diabetes management.